Primary Record
Alogliptin
- In stock
- 9,900 g
- Purity
- 99.8 %
- CAS
- 850649-61-5
Compound Identifiers & Properties
- CAS
- 850649-61-5
- PubChem CID
- 11450633
- SMILES
- CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N
- Canonical SMILES
- Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O
Names & Synonyms
- Alogliptin
- alogliptina
- 850649-61-5
- alogliptine
- vipidia
- Nesina
- alogliptinum
- Alogliptin [INN]
- Alogliptin benzoate
- Alogliptin-d3
- alogliptin tartrate
- Alogliptin/metformin
- Alogliptin (SYR-322)
- Alogliptin/pioglitazone
- Alogliptin (Standard)
- UNII-JHC049LO86
- ALOGLIPTIN [MI]
- RefChem:57142
- JHC049LO86
- Trelagliptin Impurity 30
- ALOGLIPTIN [VANDF]
- MFCD09833196
- D04ACW
- D0NJ5H
- D0Q7YI
- HSDB 8203
- 2-NP-AOZ
- SYR-322
- 2-NP-AOZ-d4
- ALOGLIPTIN [WHO-DD]
- CHEBI:72323
- SCHEMBL121028
- DTXSID90234130
- C18H21N5O2
- CHEMBL376359
- GTPL6319
- HY-A0023AR
- orb1300993
- SYR322
- 3'-Bromo-4'-fluoroacetophenone
- SCHEMBL29352995
- BDBM16285
- HY-A0023A
- A10BH04
- DTXCID90156621
- ZSBOMTDTBDDKMP-OAHLLOKOSA-N
- (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
- ALBB-038593
- alogliptin(alogliptine, alogliptina)
- AMY22119
- EX-A5446
- KS-00000FM3
- Alogliptin pound SYR-322 pound(c)
- EBC-26650
- MSK177669
- NP3015
- s2868
- s5365
- ZINC14961096
- AKOS025149226
- ACN-037216
- AN-5020
- CCG-267914
- CCG-267915
- CS-1617
- DB06203
- FA17319
- CID11450633
- NCGC00386215-04
- NCGC00386215-05
- AC-26300
- AJ-65520
- ALOGLIPTIN(ALOGLIPTINE,ALOGLIPTINA)
- AS-19582
- SC-88860
- SY077741
- Alogliptin pound SYK-322 pound(c)benzoate
- 3362B
- A4038
- NS00071194
- SW219186-1
- Y1123
- 2-({6-[(3r)-3-Aminopiperidin-1-Yl]-3-Methyl-2,4-Dioxo-3,4-Dihydropyrimidin-1(2h)-Yl}methyl)benzonitrile
- J2.587.439K
- Q-4517
- EN300-6482025
- 2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile
- A851538
- A933429
- F468425
- 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl}methyl)benzonitrile
- Q4734170
- BRD-K83003151-001-02-2
- BRD-K83003151-001-03-0
- BRD-K83003151-057-02-4
- 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile
- 850649-62-6
- Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-
- 2-[[6-[(3R)-3-amino-1-piperidyl]-3-methyl-2,4-dioxo-pyrimidin-1-yl]methyl]benzonitrile
- 1246610-75-2
- 1347001-80-2
- 2-((6-((3R)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl) benzonitrile
- 6-((R)-3-aminopiperidin-1-yl)-1-(2-cyanobenzyl)-3-methyl-1H-pyrimidine-2,4-dione
- (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitril
- (R)-2-[6-[3-Aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-ylmethyl]benzonitrile
- 1007478-57-0
- 1133421-35-8
- 19687-73-1
- 2-((6-((3R)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
- 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile; (R)-2-[6-[3-Aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-ylmethyl]benzonitrile; 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile; Alogliptin
- 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxopyrimidine-1(2H)-yl]methyl]benzonitrile
- 2-[[6-[(3R)-3-Aminopiperidine-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-yl]methyl]benzonitrile
- 2-[[6-[(3R)-3-Aminopiperidino]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-yl]methyl]benzonitrile
- 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
- Benzonitrile, 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)-
- T22